These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34331968)

  • 1. T cells protect against hepatitis A virus infection and limit infection-induced liver injury.
    Misumi I; Mitchell JE; Lund MM; Cullen JM; Lemon SM; Whitmire JK
    J Hepatol; 2021 Dec; 75(6):1323-1334. PubMed ID: 34331968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
    Das A; Hirai-Yuki A; González-López O; Rhein B; Moller-Tank S; Brouillette R; Hensley L; Misumi I; Lovell W; Cullen JM; Whitmire JK; Maury W; Lemon SM
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in
    Shiota T; Matsuda M; Zheng X; Nagata N; Ishii K; Suzuki R; Muramatsu M; Takimoto K; Hanaki KI; Lemon SM; McGivern DR; Hirai-Yuki A
    J Virol; 2022 Dec; 96(23):e0149622. PubMed ID: 36354341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.
    Sun L; Feng H; Misumi I; Shirasaki T; Hensley L; González-López O; Shiota I; Chou WC; Ting JP; Cullen JM; Cowley DO; Whitmire JK; Lemon SM
    J Hepatol; 2023 Feb; 78(2):271-280. PubMed ID: 36152761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected
    Misumi I; Li Z; Sun L; Das A; Shiota T; Cullen J; Zhang Q; Whitmire JK; Lemon SM
    J Virol; 2021 May; 95(11):e0005821. PubMed ID: 33692213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.
    Kanda T; Sasaki R; Masuzaki R; Matsumoto N; Ogawa M; Moriyama M
    Viruses; 2020 May; 12(5):. PubMed ID: 32408660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Hepatocellular Injury in Hepatitis A.
    Wang M; Feng Z
    Viruses; 2021 May; 13(5):. PubMed ID: 34066709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection.
    Zhou Y; Callendret B; Xu D; Brasky KM; Feng Z; Hensley LL; Guedj J; Perelson AS; Lemon SM; Lanford RE; Walker CM
    J Exp Med; 2012 Jul; 209(8):1481-92. PubMed ID: 22753925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.
    Win NN; Kanda T; Ogawa M; Nakamoto S; Haga Y; Sasaki R; Nakamura M; Wu S; Matsumoto N; Matsuoka S; Kato N; Shirasawa H; Yokosuka O; Okamoto H; Moriyama M
    Int J Med Sci; 2019; 16(10):1366-1370. PubMed ID: 31692913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis A virus infection. A review].
    Siegl G
    Praxis (Bern 1994); 2003 Oct; 92(40):1659-73. PubMed ID: 14579471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination.
    Acharya SK; Batra Y; Bhatkal B; Ojha B; Kaur K; Hazari S; Saraya A; Panda SK
    J Gastroenterol Hepatol; 2003 Jul; 18(7):822-7. PubMed ID: 12795755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA.
    Lanford RE; Feng Z; Chavez D; Guerra B; Brasky KM; Zhou Y; Yamane D; Perelson AS; Walker CM; Lemon SM
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11223-8. PubMed ID: 21690403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularis): evidence of active extrahepatic site of HAV replication.
    Amado LA; Marchevsky RS; de Paula VS; Hooper C; Freire Mda S; Gaspar AM; Pinto MA
    Int J Exp Pathol; 2010 Feb; 91(1):87-97. PubMed ID: 20096073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.
    Esser-Nobis K; Harak C; Schult P; Kusov Y; Lohmann V
    Hepatology; 2015 Aug; 62(2):397-408. PubMed ID: 25866017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology and inhibitors of hepatitis A virus.
    Debing Y; Neyts J; Thibaut HJ
    Med Res Rev; 2014 Sep; 34(5):895-917. PubMed ID: 23722879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.
    Li Y; Misumi I; Shiota T; Sun L; Lenarcic EM; Kim H; Shirasaki T; Hertel-Wulff A; Tibbs T; Mitchell JE; McKnight KL; Cameron CE; Moorman NJ; McGivern DR; Cullen JM; Whitmire JK; Lemon SM
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2204511119. PubMed ID: 35867748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system.
    Jiang W; Muhammad F; Ma P; Liu X; Long G
    Antiviral Res; 2018 Jun; 154():51-57. PubMed ID: 29653132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea.
    Song HJ; Kim TH; Song JH; Oh HJ; Ryu KH; Yeom HJ; Kim SE; Jung HK; Shim KN; Jung SA; Yoo K; Moon IH; Chung KW
    J Korean Med Sci; 2007 Apr; 22(2):218-22. PubMed ID: 17449927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.